(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

Many common conditions linked to aging develop without symptoms for years. Learn which five pose the biggest risks and the ...

Emerging opportunities in the C5 inhibitor market include advances in biosuperiors and biosimilars, targeting a range of C5-mediated diseases such as PNH and aHUS. Innovations focus on enhancing ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of $130.0 million aggregate principal ...

The Labour government is trying to reduce road deaths through its Road Safety Strategy, with cognitive and eyesight testing ...

Six potential changes are being considered for drivers aged 70 and over as part of a Labour Party government consultation.

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

When the uncle of Dr. David Rhew’s co-worker visited the emergency department with severe abdominal pain, he received a scan ...

More than 750,000 motorists across the UK have a medical condition that can affect their driving ability, according to recent ...

Drivers are being warned of hefty fines and prosecuted if they have medical conditions and fail to report them to the DVLA.